145 related articles for article (PubMed ID: 28960167)
1. PLGA nanoparticles with CD133 aptamers for targeted delivery and sustained release of propranolol to hemangioma.
Guo X; Zhu X; Gao J; Liu D; Dong C; Jin X
Nanomedicine (Lond); 2017 Nov; 12(21):2611-2624. PubMed ID: 28960167
[TBL] [Abstract][Full Text] [Related]
2. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres.
Guo X; Dong C; Liu Q; Zhu X; Zuo S; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108823. PubMed ID: 30965238
[TBL] [Abstract][Full Text] [Related]
3. Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth.
Guo X; Zhu X; Liu D; Gong Y; Sun J; Dong C
Int J Nanomedicine; 2017; 12():6923-6936. PubMed ID: 29075111
[TBL] [Abstract][Full Text] [Related]
4. Promotion of Propranolol Delivery to Hemangiomas by Using Anti-VEGFR Antibody-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles.
Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
J Biomed Nanotechnol; 2017 Dec; 13(12):1694-1705. PubMed ID: 29490757
[TBL] [Abstract][Full Text] [Related]
5. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
[TBL] [Abstract][Full Text] [Related]
6. Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres.
Zhu X; Guo X; Liu D; Gong Y; Sun J; Dong C
Oncol Rep; 2018 Jan; 39(1):109-118. PubMed ID: 29192323
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hemangioma growth using polymer-lipid hybrid nanoparticles for delivery of rapamycin.
Li H; Teng Y; Sun J; Liu J
Biomed Pharmacother; 2017 Nov; 95():875-884. PubMed ID: 28903183
[TBL] [Abstract][Full Text] [Related]
8. Development of rapamycin-encapsulated exosome-mimetic nanoparticles-in-PLGA microspheres for treatment of hemangiomas.
Li H; Wang X; Guo X; Wan Q; Teng Y; Liu J
Biomed Pharmacother; 2022 Apr; 148():112737. PubMed ID: 35276517
[TBL] [Abstract][Full Text] [Related]
9. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
[TBL] [Abstract][Full Text] [Related]
10. Lipid-polymer nanoparticles with CD133 aptamers for targeted delivery of all-trans retinoic acid to osteosarcoma initiating cells.
Gui K; Zhang X; Chen F; Ge Z; Zhang S; Qi X; Sun J; Yu Z
Biomed Pharmacother; 2019 Mar; 111():751-764. PubMed ID: 30612000
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.
Huang X; Huang J; Leng D; Yang S; Yao Q; Sun J; Hu J
World J Surg Oncol; 2017 Aug; 15(1):167. PubMed ID: 28854941
[TBL] [Abstract][Full Text] [Related]
12. Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma.
Zumaya ALV; Rimpelová S; Štějdířová M; Ulbrich P; Vilčáková J; Hassouna F
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163122
[TBL] [Abstract][Full Text] [Related]
13. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.
Quadros HC; Santos LMF; Meira CS; Khouri MI; Mattei B; Soares MBP; de Castro-Borges W; Farias LP; Formiga FR
Int J Pharm; 2020 Feb; 576():118997. PubMed ID: 31893542
[TBL] [Abstract][Full Text] [Related]
14. [Targeted killing of CD133
Pang L; Huang X; Zhu L; Xiao H; Li M; Guan H; Gao J; Jin H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):26-35. PubMed ID: 35249867
[TBL] [Abstract][Full Text] [Related]
15. Electrospun PLGA membrane incorporated with andrographolide-loaded mesoporous silica nanoparticles for sustained antibacterial wound dressing.
Jia Y; Zhang H; Yang S; Xi Z; Tang T; Yin R; Zhang W
Nanomedicine (Lond); 2018 Nov; 13(22):2881-2899. PubMed ID: 30427768
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs.
Hashemi M; Shamshiri A; Saeedi M; Tayebi L; Yazdian-Robati R
Arch Biochem Biophys; 2020 Sep; 691():108485. PubMed ID: 32712288
[TBL] [Abstract][Full Text] [Related]
17. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
18. Study on the Mechanism of Targeted Poly(lactic-coglycolic acid) Nano-Delivery Carriers in the Treatment of Hemangiomas.
Liao S; Wu J; Li Z; Cheng G; Lu B; Liu G; Li X; Lu W
J Nanosci Nanotechnol; 2021 Feb; 21(2):1236-1243. PubMed ID: 33183467
[TBL] [Abstract][Full Text] [Related]
19. Propranolol-Loaded Mesoporous Silica Nanoparticles for Treatment of Infantile Hemangiomas.
Wu H; Wang X; Zheng J; Zhang L; Li X; Yuan WE; Liu X
Adv Healthc Mater; 2019 May; 8(9):e1801261. PubMed ID: 30838782
[TBL] [Abstract][Full Text] [Related]
20. The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.
Jiang J; Chen H; Yu C; Zhang Y; Chen M; Tian S; Sun C
Nanomedicine (Lond); 2015 Jul; 10(12):1863-79. PubMed ID: 26139123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
